Cargando…

The C-Terminal Half of SARS-CoV-2 Nucleocapsid Protein, Industrially Produced in Plants, Is Valid as Antigen in COVID-19 Serological Tests

BACKGROUND: The fight against the current coronavirus disease 2019 (COVID-19) pandemic has created a huge demand of biotechnological, pharmaceutical, research and sanitary materials at unprecedented scales. One of the most urgent demands affects the diagnostic tests. The growing need for rapid and a...

Descripción completa

Detalles Bibliográficos
Autores principales:	Williams, Laura, Jurado, Silvia, Llorente, Francisco, Romualdo, Alberto, González, Sara, Saconne, Ana, Bronchalo, Isabel, Martínez-Cortes, Mercedes, Pérez-Gómez, Beatriz, Ponz, Fernando, Jiménez-Clavero, Miguel Ángel, Lunello, Pablo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Plant Science
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8354202/ https://www.ncbi.nlm.nih.gov/pubmed/34386028 http://dx.doi.org/10.3389/fpls.2021.699665

Ejemplares similares

Multiplex Assay for Simultaneous Detection of Antibodies against Crimean-Congo Hemorrhagic Fever Virus Nucleocapsid Protein and Glycoproteins in Ruminants
por: Hoste, Alexis C. R., et al.
Publicado: (2023)

Long-term serological surveillance for West Nile and Usutu virus in horses in south-West Spain
por: Magallanes, Sergio, et al.
Publicado: (2023)

Performance of nucleocapsid and spike-based SARS-CoV-2 serologic assays
por: Rikhtegaran Tehrani, Zahra, et al.
Publicado: (2020)

Specificity and Performance of Nucleocapsid and Spike-based SARS-CoV-2 Serologic Assays
por: Tehrani, Zahra Rikhtegaran, et al.
Publicado: (2020)

Domain-specific biochemical and serological characterization of SARS-CoV-2 nucleocapsid protein
por: Wu, Chao, et al.
Publicado: (2021)

The Detection of SARS-CoV-2 Antibodies in an Exposed Human Population Is Biased by the Immunoassay Used: Implications in Serosurveillance
por: Llorente, Francisco, et al.
Publicado: (2023)

Human post‐infection serological response to the spike and nucleocapsid proteins of SARS‐CoV‐2
por: Xiao, Cheng, et al.
Publicado: (2020)

Use of recombinant nucleocapsid proteins for serological diagnosis of feline coronavirus infection by three immunochromatographic tests
por: Takano, Tomomi, et al.
Publicado: (2014)

Experimental Infections of Wild Birds with West Nile Virus
por: Pérez-Ramírez, Elisa, et al.
Publicado: (2014)

The C-Terminal Portion of the Nucleocapsid Protein Demonstrates SARS-CoV Antigenicity
por: Liu, Guozhen, et al.
Publicado: (2003)

Oligomerization of the carboxyl terminal domain of the human coronavirus 229E nucleocapsid protein
por: Lo, Yu-Sheng, et al.
Publicado: (2013)

Nuclear/nucleolar localization properties of C-terminal nucleocapsid protein of SARS coronavirus
por: Timani, Khalid Amine, et al.
Publicado: (2005)

Engineered recombinant protein products of the avian paramyxovirus type-1 nucleocapsid and phosphoprotein genes for serological diagnosis
por: Zhao, Na, et al.
Publicado: (2018)

Recombinant nucleocapsid protein-based IgG enzyme-linked immunosorbent assay for the serological diagnosis of SARS
por: Saijo, Masayuki, et al.
Publicado: (2005)

Serological detection of antibodies to the SARS-CoV-2 nucleocapsid protein from dried blood spots
por: Dhar, Arko, et al.
Publicado: (2022)

Structural Basis for the Identification of the N-Terminal Domain of Coronavirus Nucleocapsid Protein as an Antiviral Target
por: Lin, Shing-Yen, et al.
Publicado: (2014)

Structural characterization of the C-terminal domain of SARS-CoV-2 nucleocapsid protein
por: Zhou, Renjie, et al.
Publicado: (2020)

Calcium-controlled conformational choreography in the N-terminal half of adseverin
por: Chumnarnsilpa, Sakesit, et al.
Publicado: (2015)

Importance of MHV-CoV A59 Nucleocapsid Protein Cooh-Terminal Negative Charges
por: Bednar, Valerie, et al.
Publicado: (2006)

Crystallographic analysis of the N-terminal domain of Middle East respiratory syndrome coronavirus nucleocapsid protein
por: Wang, Yong-Sheng, et al.
Publicado: (2015)

The Inherent Dynamics and Interaction Sites of the SARS-CoV-2 Nucleocapsid N-Terminal Region
por: Redzic, Jasmina S., et al.
Publicado: (2021)

Antibodies Produced Toward Recombinant RBD and Nucleocapsid Neutralize SARS-COV-2
por: Rezaei, Amir, et al.
Publicado: (2022)

Mapping of B-cell epitopes on the N- terminal and C-terminal segment of nucleocapsid protein from Crimean-Congo hemorrhagic fever virus
por: Moming, Abulimiti, et al.
Publicado: (2018)

Expression and purification of recombinant SARS-CoV-2 nucleocapsid protein in inclusion bodies and its application in serological detection
por: Li, Guang, et al.
Publicado: (2021)

Cross-Reactivity of SARS-CoV-2 Nucleocapsid-Binding Antibodies and Its Implication for COVID-19 Serology Tests
por: Rak, Alexandra, et al.
Publicado: (2022)

Predicting Individual Changes in Terminal Half-Life After Switching to Extended Half-Life Concentrates in Patients With Severe Hemophilia
por: Versloot, Olav, et al.
Publicado: (2022)

Quantum Chemical Lipophilicities of Antimalarial Drugs in Relation to Terminal Half-Life
por: Alia, Joseph D., et al.
Publicado: (2020)

Characterization of Two Monoclonal Antibodies That Recognize Linker Region and Carboxyl Terminal Domain of Coronavirus Nucleocapsid Protein
por: Zhang, Xin, et al.
Publicado: (2016)

A key role for the carboxy-terminal tail of the murine coronavirus nucleocapsid protein in coordination of genome packaging
por: Kuo, Lili, et al.
Publicado: (2016)

Characterisation of the RNA binding properties of the coronavirus infectious bronchitis virus nucleocapsid protein amino‐terminal region
por: Spencer, Kelly-Anne, et al.
Publicado: (2006)

Suramin Disturbs the Association of the N-Terminal Domain of SARS-CoV-2 Nucleocapsid Protein with RNA
por: Guo, Chenyun, et al.
Publicado: (2023)

Antiviral drug design based on structural insights into the N-terminal domain and C-terminal domain of the SARS-CoV-2 nucleocapsid protein
por: Luan, Xiaodong, et al.
Publicado: (2022)

Two serological approaches for detection of antibodies to SARS-CoV-2 in different scenarios: a screening tool and a point-of-care test
por: Hoste, Alexis C.R., et al.
Publicado: (2020)

Severe acute respiratory syndrome coronavirus nucleocapsid protein confers ability to efficiently produce virus-like particles when substituted for the human immunodeficiency virus nucleocapsid domain
por: Wang, Shui-Mei, et al.
Publicado: (2008)

Functional analyses of the C-terminal half of the Saccharomyces cerevisiae Rad52 protein
por: Kagawa, Wataru, et al.
Publicado: (2014)

Nucleocapsid Assembly of Baculoviruses
por: Zhao, Shuling, et al.
Publicado: (2019)

Expression, crystallization and preliminary crystallographic study of mouse hepatitis virus (MHV) nucleocapsid protein C-terminal domain
por: Tong, Xiaohang, et al.
Publicado: (2010)

Thermostability of the N-Terminal RNA-Binding Domain of the SARS-CoV Nucleocapsid Protein: Experiments and Numerical Simulations
por: Fang, Huey-Jen, et al.
Publicado: (2009)

Solution Structure of the C-terminal Dimerization Domain of SARS Coronavirus Nucleocapsid Protein Solved by the SAIL-NMR Method
por: Takeda, Mitsuhiro, et al.
Publicado: (2008)

The Nucleocapsid Protein of Coronavirus Infectious Bronchitis Virus: Crystal Structure of Its N-Terminal Domain and Multimerization Properties
por: Fan, Hui, et al.
Publicado: (2005)

Cannot write session to /tmp/vufind_sessions/sess_73oaqq9u552bstm5h12mlhtn9f